Genotype and risk of major bleeding during warfarin treatment.

Kawai VK, Cunningham A, Vear SI, Van Driest SL, Oginni A, Xu H, Jiang M, Li C, Denny JC, Shaffer C, Bowton E, Gage BF, Ray WA, Roden DM, Stein CM
Pharmacogenomics. 2014 15 (16): 1973-83

PMID: 25521356 · PMCID: PMC4304738 · DOI:10.2217/pgs.14.153

MeSH Terms (20)

Adult Aged Biological Specimen Banks Cytochrome P-450 CYP2C9 Cytochrome P-450 Enzyme System Cytochrome P450 Family 4 Dose-Response Relationship, Drug Ethnic Groups Female Gene Frequency Genetic Association Studies Genetic Variation Genotype Hemorrhage Humans Male Middle Aged Risk Factors Vitamin K Epoxide Reductases Warfarin

Connections (4)

This publication is referenced by other Labnodes entities: